Publications in other proceedings
-
BCTRIMS 2024
FCGR2A rs1801274 polymorphism is associated with response to natalizumab in multiple sclerosis patients
-
FRONTIERS 2024
Genetic variants in FCGR2A, PTPN2, VDR as Predictive Signatures of Aggressive Phenotypes in Cerebral Cavernous Malformation
-
FRONTIERS 2024
FCGR2A variant rs1801274 as a Pharmacogenetic Predictor of Natalizumab Therapeutic Failure in Multiple Sclerosis Patients
-
FRONTIERS 2024
TLR4 genetic variants in the interface between gut-brain axis and Natalizumab response in Multiple Sclerosis patients.
Streamline your Scholarly Event
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
